Article Sidebar

Submitted
April 19, 2025
Accepted
June 1, 2025
Published
June 30, 2025
Download
PDF
Statistic
Read Counter : 45

Main Article Content

Abstract

This paper presents a historical overview of drug addiction since it follows its beginnings that stretch to 7000 years B.C, it also identifies different concepts related to drugs, including intoxicants, hashish, medicines, painkillers, volatile solvents, light addictive stimulants, and abused pharmaceuticals. In addition, this paper tackles the impacts of drug use, clarifies the relation between drugs, painkillers, and addiction, outlines the differences between drug users and addicts, and discusses the factors contributing to addiction. The paper takes a deep dive into drug addiction theories like the physiological theory, abuse prevention theory, commitment to tradition and social bonding, risk, and protective factors theory, and intrapersonal theory, and specifies the general effects and disorders associated with addictive substances, alcohol, and ethanol addicts' behavior and addiction disorders.

Keywords

Drug use Addiction Drugs/narcotics Pharmaceuticals Intoxicants Hallucinogens Stimulants

Article Details

How to Cite
1.
Hiba Hussein Fadil Mahdi, Ghassan Jasim Mohammed. Impacts of Drug Abuse and Addiction and Effects of Pharmaceuticals Misuse: Review Article. JBB [Internet]. 2025 Jun. 30 [cited 2025 Sep. 28];4(2):42-56. Available from: http://biomedbiochem.nabea.pub/biomedbiochem/article/view/90
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

How to Cite

1.
Hiba Hussein Fadil Mahdi, Ghassan Jasim Mohammed. Impacts of Drug Abuse and Addiction and Effects of Pharmaceuticals Misuse: Review Article. JBB [Internet]. 2025 Jun. 30 [cited 2025 Sep. 28];4(2):42-56. Available from: http://biomedbiochem.nabea.pub/biomedbiochem/article/view/90
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Leshner AI. Addiction is a brain disease, and it matters. Science. 1997 Oct 3;278(5335):45-7. doi: https://doi.org/10.1126/science.278.5335.45.
  2. Margolis RD, Zweben JE. Treating patients with alcohol and other drug problems: an integrated approach. Washington (DC): American Psychological Association; 1998. doi: https://doi.org/10.1037/10289-000.
  3. Chai XY, Tham CL. Drug discovery and development: a historical overview, current challenges and perspectives. Life Sci Med Biomed. 2024;8(1):137. doi: https://doi.org/10.28916/lsmb.8.1.2024.137.
  4. Khalsa JH, Francis H, Mazin R. Bloodborne and sexually transmitted infections in drug abusers in the United States, Latin America, the Caribbean, and Spain. Clin Infect Dis. 2003 Dec 15;37 Suppl 5:S331-7. doi: https://doi.org/10.1086/377543.
  5. Njati IC. Drug abuse and addiction effects on human body. IOSR J Humanit Soc Sci. 2016 Sep;21(9):54-57. doi:https://doi.org/10.9790/0837-2109035457.
  6. Withington P. Intoxicants and the invention of 'consumption'. Econ Hist Rev. 2019;0(0):1-25.DOI: https://doi.org/10.1111/ehr.12936.
  7. Withington P. Addiction, Intoxicants, and the Humoral Body. The Historical Journal. 2022;65(1):68–90. doi: https://doi.org/10.1017/S0018246X21000194.
  8. Mokha IS. The psychology of addiction and factors contributing to substance abuse. EPRA Int J Multidiscip Res. 2024 Feb 15;10(2):2455-3662. DOI: https://doi.org/10.36713/epra2013.
  9. Badia R, Segura J, Artola A, de la Torre R. Survey on drugs-of-abuse testing in the European Union. J Anal Toxicol. 1998;22(2):117-26. DOI: https://doi.org/10.1093/jat/22.2.117.
  10. Kapur BM. Drug-testing methods and clinical interpretations of test results. Bull Narc. 1993;45(2):115-54.DOI: https://doi.org/10.1007/978-1-4615-2399-4_5.
  11. Garcia-Romeu A, Kersgaard B, Addy PH. Clinical applications of hallucinogens: a review. Exp Clin Psychopharmacol. 2016;24(4):229-68.DOI: https://doi.org/10.1037/pha0000084.
  12. Caday BDF. Causes of drug abuse among college students: the Philippine experience. Int J Soc Sci Humanit Invention. 2017;4(4):3430-4., DOI: https://doi.org/10.18535/ijsshi/v4i4.05.
  13. P. Nkhoma and F. Maforah, "Drinking patterns among students in a university self-catering residence at the University of Cape Town," Urbanisation and Health Newsletter, vol. 21, p. 54, 1994, DOI: https://doi.org/10.51415/10321/4906.
  14. [Stafstrom M, Agarth A. Socio-economic determinants for alcohol consumption and heavy episodic drinking in a Ugandan student population. Int J Alcohol Drug Res. 2012;1(1):57-67., DOI: https://doi.org/10.7895/ijadr.v1i1.40.
  15. Odek-Ogunde M, Pande-Leak D. Prevalence of substance use among students in a Kenyan university: a preliminary report. East Afr Med J. 1999;76(6):301-6.
  16. NACADA. Report on rapid situation assessment of drug and substance abuse in Kenya. Nairobi: Government Printer; 2012.
  17. Velleman R, Templeton L. Reaching out – promoting resilience in the children substance misusers. In: Evans D, Harbin F, Murphy M, editors. Secret lives: understanding and working with children who live with substance misuse. Rossall House Publishers; 2005. p. 12-28.
  18. Maithya R. Drug abuse in secondary schools in Kenya: developing a programme for prevention and intervention. Saarbrücken: LAP Lambert Academic Publishing; 2012.
  19. Chesang RK. Drug abuse among the youth in Kenya. Int J Sci Technol Res. 2013;2:126-31.
  20. Agcaoili NP. Drugs in the school. Mod Teacher. 2005;LIV(6)..
  21. Fekadu A, Atalay A, Charlotte H. Alcohol and drug abuse in Ethiopia: past, present and future. Afr J Drug Alcohol Stud. 2007;6(1):39-53.
  22. Baron M. Addiction treatment for Mexican American families. In: Krestan JA, editor. Bridges to recovery: addiction, family therapy, and multicultural treatment. New York: The Free Press; 2000. p. 219-52.
  23. Agrawal A, Dick D. Are there genetic influences on addiction? Evidence from family, adoption and twin studies. Addiction. 2008;103(7):1069-81.
  24. Kirkok SK, Kibet JK. The scope of tobacco abuse in Kenya and interventions taken to promote cessation: a review. Open Access Libr J. 2019;6(8):1-18. doi:10.4236/oalib.1105578, DOI: https://doi.org/10.4236/oalib.1105578.
  25. Humensky JL. Are adolescents with high socio-economic status more likely to engage in alcohol and illicit drug use in early adulthood? Subst Abuse Treat Prev Policy. 2010;5(1):19, DOI: https://doi.org/10.1186/1747-597X-5-19.
  26. Mounteney J, Griffiths P. Increasing complexity in European drug use: highlights from the EMCDDA’s 2014 European drug report. Drugs Educ Prev Policy. 2014;21(6):482-3, DOI: https://doi.org/10.3109/09687637.2014.963516.
  27. Giancola PR, Dominic JP. Differential effects of past year stimulant and sedative drug use on alcohol-related aggression. Addict Behav. 2005;30(8):1535-54, DOI: https://doi.org/10.1016/j.addbeh.2005.02.011.
  28. Room R. Stigma, social inequality and alcohol and drug use. Drug Alcohol Rev. 2005;24(2):143-55, DOI: https://doi.org/10.1080/09595230500102434.
  29. Smart RG, Murray GF. Narcotic drug abuse in 152 countries: social and economic conditions as predictors. Int J Addict. 1985;20(5):737-49, DOI: https://doi.org/10.3109/10826088509044293.
  30. Chibi B, et al. Prescription drug diversion, misuse, and abuse among people living with HIV: a scoping review protocol. Syst Rev. 2020;9(1):29, DOI: https://doi.org/10.1186/S13643-020-1273-4.
  31. Meyer DG. A developmental psychopathology model of drug abuse vulnerability. Washington (DC): American Psychological Association Press; 1992. p. 389-418, DOI: https://doi.org/10.1037/10107-000.
  32. Baumrind D, Moselle KA. A developmental perspective on adolescent drug abuse. J Addict Dis. 1985;4(3-4):41-67, DOI: https://doi.org/10.1300/J251v04n03_03.
  33. Liddle HA, Dakof GA, Parker K, Diamond GS, Barrett K, Tejeda M. Multidimensional family therapy for adolescent drug abuse: results of a randomized clinical trial. Am J Drug Alcohol Abuse. 2001;27(4):651-88, DOI: https://doi.org/10.1081/ADA-100107661.
  34. Kuppin S, Carpiano RM. Public conceptions of serious mental illness and substance abuse, their causes and treatments: findings from the 1996 general social survey. Am J Public Health. 2011;96(10):1766-71. DOI: https://doi.org/10.2105/AJPH.2004.060855.
  35. Inciardi JA, et al. Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment. Pain Med. 2009;10(3):537-48.DOI: https://doi.org/10.1111/j.1526-4637.2009.00603.x
  36. Levine HG. Global drug prohibition: its uses and crises. Int J Drug Policy. 2003;14(2):145-53, DOI: https://doi.org/10.1016/S0955-3959(03)00003-3.
  37. Siste K, Nugraheni P, Christian H, Suryani E, Firdaus KK. Prescription drug misuse in adolescents and young adults: an emerging issue as a health problem. Curr Opin Psychiatry. 2019;32(4):320-7, DOI: https://doi.org/10.1097/YCO.0000000000000520.
  38. Larney S, Peacock A, Bradley M, Hickman M, Degenhardt L. A systematic review of injecting-related injury and disease among people who inject drugs. Drug Alcohol Depend. 2017;171:39-49, DOI: https://doi.org/10.1016/j.drugalcdep.2016.11.029.
  39. Ashraf IH, Mohammed F, Al-Wakeel AMM. Drug abuse and related crimes: review article. Al-Azhar Med J. 2016;45(1):35-47, DOI: https://doi.org/10.12816/0026266.
  40. Bassiony MM, Salah El-Deen GM, Yousef U, Raya Y, et al. Adolescent tramadol use and abuse in Egypt. Am J Drug Alcohol Abuse. 2015;41(3):206-11, DOI: https://doi.org/10.3109/00952990.2015.1014959.
  41. Pfrimmer DM. Recognizing and preventing drug diversion. Nurs Crit Care. 2015;10(6):5-9.DOI: https://doi.org/10.1097/01.CCN.0000472850.93302.
  42. Fitzsimons MG, Soares de Sousa G, Galstyan A, Quintão VC, Simões CM. Prevention of drug diversion and substance use disorders among anesthesiologists: a narrative review. Braz J Anesthesiol. 2023;73(6):810-8. DOI: https://doi.org/10.1016/j.bjane.2023.07.008.
  43. Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths — United States, 2013-2017. MMWR Morb Mortal Wkly Rep. 2018;67(5152):1419-27.DOI: : https://doi.org/10.15585/mmwr.mm675152e1.
  44. McCall Jones C, Baldwin GT, Compton WM. Recent increases in cocaine-related overdose deaths and the role of opioids. Am J Public Health. 2017;107(3):430-2.DOI: https://doi.org/10.2105/AJPH.2016.303627.
  45. Helmerhorst GT, Teunis T, Janssen SJ, Ring D. An epidemic of the use, misuse and overdose of opioids and deaths due to overdose, in the United States and Canada: is Europe next? Bone Joint J. 2017;99(7):856-64. DOI: https://doi.org/10.1302/0301-620X.99B7.BJJ-2016-1350.R1.
  46. Volkow N, Benveniste H, McLellan AT. Use and misuse of opioids in chronic pain. Annu Rev Med.DOI: https://doi.org/10.1146/annurev-med-011817-044739.
  47. Amsterdam VJ, Brink vd W. The misuse of prescription opioids: a threat for Europe? Curr Drug Abuse Rev. 2015;8(1):3-14. DOI: https://doi.org/10.2174/187447370801150611184218.
  48. Compton WM, Jones CM, Baldwin GT. Nonmedical prescription-opioid use and heroin use. N Engl J Med. 2016;374(13):1296. DOI: https://doi.org/10.1056/NEJMc1601875.
  49. ones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers — United States, 2002-2004 and 2008-2010. Drug Alcohol Depend. 2013;132(1-2):95-100.DOI: https://doi.org/10.1016/j.drugalcdep.2013.01.007.
  50. Hill J, Alford DP. Prescription medication misuse. Semin Neurol. 2018;38(6):654-64. DOI: https://doi.org/10.1055/S-0038-1673691.
  51. Kurtz SP, Buttram ME, Margolin ZR, Wogenstahl K. The diversion of nonscheduled psychoactive prescription medications in the United States, 2002 to 2017. Pharmacoepidemiol Drug Saf. 2019;28(5):700-6.DOI: https://doi.org/10.1002/PDS.4771.
  52. Birckmayer JD, Holder HD, Yacoubian GS, Friend KB. A general causal model to guide alcohol, tobacco, and illicit drug prevention: assessing the research evidence. J Drug Educ. 2004;34(2):121-53. DOI: https://doi.org/10.2190/PYL2-FF8N-6B6C-A57R.
  53. Zipporrah AH, Githae MN, Gideon M. Knowledge on use and effects of drug and substance abuse among youth aged 13 to 24 years in Raila Village, Kibera Slum, Nairobi, Kenya. Int J Contemp Res Rev. 2018;9(8):20575-20601. DOI: https://doi.org/10.15520/ijcrr/2018/9/08/575.